Keywords: ec, approves, intelence, european, commission, granted, marketing

EC approves J&J's Intelence

Article | 08 September 2008

The European Commission has granted marketing authorization for Intelence (etravirine), a next-generation non-nucleoside reverse transcriptase inhibitor and the first approved ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Entravirine Tablets

Intelence

Go to drug listing